Board Meeting Details

The Board of Directors meeting was held on Saturday, October 31, 2026 at 11:30 A.M through Video Conferencing/Other Audio Visual Means (VC/OAVM). The meeting concluded at 12:10 P.M.

Business Transacted and Approved

The Board approved:

  • The Standalone and Consolidated Un-audited financial results for the half year ended September 30, 2026 as per Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • The Statement of Assets and Liabilities and Cash Flow Statement as on September 30, 2026
  • The Limited Review Report

Standalone Financial Performance (Figures in Lakhs of Rupees)

Income Statement Highlights (Half Year Ended September 30, 2026)

  • Revenue from operations: ₹5,567.45
  • Other Income: ₹78.53
  • Total Income: ₹5,986.91
  • Cost of Material Consumed: ₹4,409.09
  • Employee Benefits Expenses: ₹265.19
  • Depreciation and Amortization Expenses: ₹81.32
  • Finance Costs: ₹4.64
  • Other Expenses: ₹512.76
  • Total Expenditure: ₹5,470.50
  • Profit before tax: ₹515.52
  • Tax Expense: ₹175.50
  • Net Profit for the period: ₹340.22
  • Basic EPS: ₹2.53 (not annualized)
  • Diluted EPS: ₹2.53 (not annualized)

Balance Sheet Position (As at September 30, 2026)

  • Share Capital: ₹1,345.96
  • Reserves and Surplus: ₹3,740.03
  • Total Shareholders' Funds: ₹5,085.99
  • Long term borrowings: ₹60.87
  • Trade Payables: ₹71,894 (₹47,237 to micro/small enterprises + ₹24,657 to others)
  • Total Assets: ₹6,346.30
  • Property, Plant and Equipment: ₹98.58
  • Inventories: ₹3,056.24
  • Trade Receivables: ₹542.41
  • Cash and Bank Balances: ₹1,095.85

Cash Flow Statement (Half Year Ended September 30, 2026)

  • Net Cash from Operating Activities: (₹10.91)
  • Net Cash from Investing Activities: (₹110.74)
  • Net Cash from Financing Activities: (₹27.98)
  • Net Decrease in Cash: (₹24.97)
  • Cash at beginning: ₹567.38
  • Cash at end: ₹542.42

Consolidated Financial Performance (Figures in Lakhs of Rupees)

Income Statement Highlights (Half Year Ended September 30, 2026)

  • Revenue from operations: ₹5,662.81
  • Other Income: ₹20.57
  • Total Income: ₹5,683.38
  • Cost of Material Consumed: ₹4,147.10
  • Employee Benefits Expenses: ₹266.56
  • Depreciation and Amortization Expenses: ₹78.95
  • Finance Costs: ₹6.64
  • Other Expenses: ₹538.65
  • Total Expenditure: ₹5,208.61
  • Profit before tax: ₹474.77
  • Tax Expense: ₹182.42
  • Net Profit for the period: ₹292.35
  • Basic EPS: ₹2.17 (not annualized)
  • Diluted EPS: ₹2.17 (not annualized)

Balance Sheet Position (As at September 30, 2026)

  • Share Capital: ₹1,345.96
  • Reserves and Surplus: ₹3,693.15
  • Total Shareholders' Funds: ₹5,039.11
  • Long term borrowings: ₹60.87
  • Trade Payables: ₹80,617 (₹47,237 to micro/small enterprises + ₹33,380 to others)
  • Total Assets: ₹6,394.80

Cash Flow Statement (Half Year Ended September 30, 2026)

  • Net Cash from Operating Activities: ₹199.42
  • Net Cash from Investing Activities: (₹155.27)
  • Net Cash from Financing Activities: (₹27.97)
  • Net Increase in Cash: ₹16.18
  • Cash at beginning: ₹568.38
  • Cash at end: ₹584.56

Subsidiary Information

The consolidated results include Regranix Private Limited, a subsidiary incorporated in March 2026. Comparative figures for the subsidiary are not available for the half year ended September 2025.

Auditor Review

Independent auditor Ajmera & Ajmera (FRN: 018796C) issued unmodified review reports for both standalone and consolidated financial results, concluding that nothing came to their attention causing them to believe the statements contain material misstatements.

Accounting Policies and Notes

The financial statements are prepared in accordance with Indian Generally Accepted Accounting Principles (IGAAP) under historical cost convention. The company operates in only one segment [plastics manufacturing].

Historical Context

The company completed its IPO in financial year 2020-21 with fresh issue of 3,22,800 equity shares and offer for sale of 1,88,000 equity shares. Bonus issues were made in 2020-21 (15:1 ratio) and 2022-23 (6:1 ratio).

The company is listed on BSE SME platform and is exempt from IND-AS applicability.